Regulatory Updates
🌏 NMPA Page 3NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 25–36 of 87 articles
CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy
Hong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know
Rusan Pharma Secures PMDA GMP Approval, Boosting Global Market Access
Estado Actual y Acciones para Impulsar la Investigación Clínica en México: 2025
GlycoNex Secures PMDA Approval for GNX1021 Phase I Trial
Pharmaceuticals Market Size and Share Analysis for 2034
Disparities in Early Access to Innovative Therapies: A Global Overview
Biomarkers and Digital Technologies Transforming Oncology in Asia
Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights
UK Clinical Trials in Oncology: Actions Driving Impact
Innovative Oncology Pharma Companies in China: A Look Ahead
MannKind's Pediatric Expansion: A New Era for Afrezza